Amundi Asset Management US’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $208M | Buy |
|
|||||
2020
Q4 | $193M | Buy |
|
|||||
2020
Q3 | $118M | Sell |
|
|||||
2020
Q2 | $132M | Sell |
|
|||||
2020
Q1 | $125M | Buy |
|
|||||
2019
Q4 | $61.7M | Sell |
|
|||||
2019
Q3 | $48.6M | Sell |
|
|||||
2019
Q2 | $55.7M | Buy |
|
|||||
2019
Q1 | $49.9M | Buy |
|
|||||
2018
Q4 | $33.3K | Sell |
|
|||||
2018
Q3 | $40.5M | Buy |
|
|||||
2018
Q2 | $33.3M | Sell |
|
|||||
2018
Q1 | $208M | Sell |
|
|||||
2017
Q4 | $193M | Buy |
|
|||||
2017
Q3 | $193M | Sell |
|
|||||
2017
Q2 | $171M | Sell |
|
|||||
2017
Q1 | $166M | Buy |
|
|||||
2016
Q4 | $90.3M | Sell |
|
|||||
2016
Q3 | $107M | Buy |
|
|||||
2016
Q2 | $95.6M | Buy |
|
|||||
2016
Q1 | $69.7M | Buy |
|
|||||
2015
Q4 | $96.6M | Buy |
|
|||||
2015
Q3 | $69.9M | Sell |
|
|||||
2015
Q2 | $92M | Sell |
|
|||||
2015
Q1 | $93.7M | Buy |
|
|||||
2014
Q4 | $76.9M | Sell |
|
|||||
2014
Q3 | $74.3M | Sell |
|
|||||
2014
Q2 | $80.5M | Sell |
|
|||||
2014
Q1 | $84.6M | Sell |
|
|||||
2013
Q4 | $90.4M | Sell |
|
|||||
2013
Q3 | $94M | Buy |
|
|||||
2013
Q2 | $88.5M | Buy |
|